Claim OwnershipLungcast
Subscribed: 21Played: 277
Subscribe
Description
Join the American Lung Association and HCPLive every month as Dr. Al Rizzo interviews world-leading experts on the great challenges, accomplishments, and stories in respiratory medicine.
Get the latest lung health news, including future Lungcast topics and guests, by signing up for our newsletter at Lung.org.
Get the latest lung health news, including future Lungcast topics and guests, by signing up for our newsletter at Lung.org.
68 Episodes
Reverse
To capture the breadth of the past year's discussions, HCPLive presents this Lungcast 2025 recap episode, highlighting a selection of standout conversations from across the series. While far from exhaustive, this collection reflects the themes, questions, and breakthroughs that defined the year in respiratory medicine and underscores Lungcast’s ongoing role as a forum for informed, forward-looking dialogue in pulmonary care.The episodes sampled are listed below:
Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD (00:17)
After the Smoke: Wildfire Cleanup & Air Quality Concerns with Afif El-Hasan, MD (01:51)
Lung Cancer Screening: A Decade of Lessons Learned with Mary Pasquinelli, DNP (03:14)
2025 State of the Air: Dangers of the Air We Breathe with George Thurston, ScD (04:17)
Going for GOLD: Updated COPD Guidelines with Gerard Criner, MD (05:43)
The Lung-Gut Axis - Where Nutrition & Lung Health Intersect with Neal Barnard, MD (07:32)
Resilience and Sustainability: Preparing Healthcare for the Future with Elizabeth Cerceo, MD (08:20)
In this episode, we are joined by Elizabeth Cerceo, MD to explore the critical role of resilience and sustainability in the healthcare industry. The discussion highlights how healthcare systems can adapt to crises like extreme weather events and pandemics while maintaining quality care. It also examines how sustainability efforts can reduce environmental impacts and safeguard health for future generations.
While major advances in screening, targeted treatment and immunotherapy have transformed outcomes for non-small cell lung cancer, progress against small cell lung cancer (SCLC) has lagged behind. In this episode, Jacob Sands, MD, of Dana-Farber Cancer Institute and Harvard Medical School joins us to share insights into the present state of SCLC treatment, from staging and standard therapies to new research on vaccines that could one day change the course of this aggressive disease.
Microbiome is a mysterious medical frontier with more questions than answers. In this episode, nutrition expert Neal Barnard, MD, of George Washington University explores the connection between diet, gut microbiome and lung health. While fiber and plant-based diets have been shown to shape a healthier microbiome, this conversation sheds light on the growing evidence that what we eat may have far-reaching effects beyond the gut—including in our lungs.
This episode featuring clinician-scientist and expert in liquid biopsy development, Dr. Lindsey Cotton, who explores the evolving science of lung cancer biomarkers and their role in early detection. Listen in to learn more about the current landscape, benefits and challenges of both organ-specific and multi-cancer tests. The highly informative discussion aims to clarify what these tests can and cannot tell us today, along with a forecast for tomorrow.
Earlier this year, the Global Initiative for Obstructive Lung Disease (GOLD) guidelines were updated to include a new emphasis on cardiovascular disease and pulmonary hypertension in COPD, among much more. Rejoining us for an episode exploring these revisions is Gerard Criner, MD, of Temple University, a foremost COPD expert who serves on the GOLD Board of Directors and GOLD Science Committee. He spells out the improvements, from interventions like smoking cessation and pulmonary rehabilitation to the heightened importance of spirometry for diagnosis.
This special episode features 2 interviews on-site at the 2025 American Thoracic Society (ATS) International Conference in San Francisco: Harold P. Wimmer, CEO of the American Lung Association, and Francesca Polverino, MD, PhD, a professor at Baylor College of Medicine and spokesperson for the ALA.
View the latest conference coverage from this meeting here: https://www.hcplive.com/conference/ats
#Lungcast #HealthNews
An internationally recognized leader in air quality, epidemiology and exposure assessment, George Thurston, ScD, of New York University headlines this important episode analyzing the Lung Association’s 2025 “State of the Air” report. With nearly half of the people living in the U.S. breathing unhealthy amounts of air pollution, Thurston delves into the acute and accumulative health impacts on communities across the country. Listen in to learn more about the report’s key learnings, from adverse effects of exposure to ground-level ozone pollution to the decade-long worsening trend of particle pollution.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
It has been more than a decade since lung cancer screening guidelines via low-dose CT, based on the USPSTF’s B recommendations, have been put into place. To discuss the guidelines’ ambitions and obstacles, we are joined by the University of Illinois Health System’s Mary Pasquinelli, DNP, who specializes in lung cancer, lung cancer screening and pulmonary nodule management. While a lifesaving procedure for at-risk individuals, the uptake of screening on a population-level—though increasing—has been slower than expected.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
For this hot topic, asthma and lung health expert Dr. Afif El-Hasan of Kaiser Permanente in California joins host Dr. Albert Rizzo to discuss the acute effects of wildfire smoke on air quality. The enlightening conversation also covers the massive cleanup efforts from the recent Los Angeles wildfires and how related exposures may pose health risks.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
In this episode, Dr. Meredith McCormack of Johns Hopkins University and Dr. Loretta Que of Duke University to discuss “race-based normal values” in medicine, particularly in regard to pulmonary function tests (PFT).
The controversial practice of using a patient’s self-reported race to adjust a standard “normal” range has been shown to lead to potential misdiagnosis and healthcare disparities. Drs. McCormack and Que talk at length about their key roles in the growing movement to phase out a reliance on race in PFT interpretation.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Ever since the show first launched, Lungcast has provided pulmonologists and health care providers in general a chance to take part in ongoing conversations regarding lung health between experts, patients, and patient advocates.
In this recap episode, the Lungcast team reflects on these conversations by highlighting some of the many interviews featured in 2024. The following are a set of examples of this year’s interviews, though several other memorable episodes are not on this list. We hope you enjoy this set of highlights.
For more, view a summary here: https://www.hcplive.com/view/this-year-in-pulmonology-a-2024-lungcast-recap
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targeted mutations, Dr. Sands addresses how precision oncology is fundamentally changing lung cancer diagnosis and treatment.
The novel immunotherapy drugs, though proven to be safe and effective with significant improvements in response and survival rates, have challenges as well—this episode covers the gamut.
Episode Highlights
0:00 Start
1:00 Topic of discussion
2:42 Introducing Jacob Sands, MD
3:39 NCCN guidelines for lung cancer
6:51 Recently-approved drugs for lung cancer
13:46 Patient responses to targeted mutations
17:58 Off-target side effects with drugs
21:34 State of Lung Cancer report
23:04 Estimated number of candidates for targeted therapies
26:13 Insurance coverage for biomarker testing
28:12 Other issues with ordering biomarkers
31:20 Closing comments
32:36 Outro
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
In this episode, multiple points of view are presented regarding Asthma Exacerbated Respiratory Disease (AERD). Lungcast host Albert Rizzo, MD, was joined by allergist and immunologist Mitchell Grayson, MD, of Nationwide Children’s Hospital, as well as patient advocate Rhonda Nelson and her husband Wayne Nelson of The Little River Band. This discussion delves into the trials and tribulations of diagnosing—and living with—AERD, from disease misconceptions to daily management.
Join the discussion as these guests focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.
Episode Highlights
0:00 Start
1:00 Focus of each guest
2:55 Sampter’s triad and AERD
6:30 Patient experiences with AERD
10:18 Delayed diagnosis and recent changes
11:35 Therapy for AERD
16:32 Resources for patients with asthma
19:01 Day-to-day AERD management
24:14 Importance of keeping a medical journal
27:42 Outro
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Episode Highlights
0:15 Intro
1:10 Introducing the Lung Health Cohort Research Study
3:49 The enrollment strategy
7:10 Seeking “the cholesterol of lung disease”
11:50 The role of industry support
14:09 Imaging strategies for long-term lung assessment
17:59 Recruitment challenges
23:05 Final thoughts
26:20 Outro
For our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Cohort Research Study.
Tune in to learn more about their collaborative efforts to help identify biomarkers and lifestyle patterns for more accurate identification of disease processes, ideally at onset.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
In this episode, Dr. Rachel Eddy of the University of British Columbia explores the evolving field of medical imaging technology and the transformative impact of artificial intelligence. While applications of AI have expanded beyond traditional radiology, it delves into cutting-edge techniques like 3D printing and molecular imaging that are redefining diagnostics and treatment planning.
Join us as we focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.
Episode Highlights
0:15 Intro
1:10 The history of medical imaging technology
3:02 Artificial intelligence terminology
8:56 Use of AI to assess asthma airway and mucus changes
13:02 Imaging biomarkers for ILD
16:52 Using AI to observe longterm decline of lung function
21:00 Dysanapsis analysis through CT scans
24:04 Xenon-enhanced MRIs for microstructural lung abnormalities
28:50 How will AI us continue to evolve in pulmonology?
31:58 Outro
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Episode Highlights
0:16 Intro
2:24 Asthma action plans
3:52 Asthma Peak Week
6:28 School nurse’s role
11:05 SMART inhaler strategy for kids
14:25 Addressing vaping among students
20:18 Discussing vaccines with children and parents
24:01 School air quality issues?
27:50 Final thoughts
29:42 Outro
As families jump into the new school year, this episode brings together Chicago-based allergist and immunologist Dr. Juanita Mora and pediatric pulmonologist Dr. S. Christy Sadreameli of Johns Hopkins Hospital to share their tips for making the return to school as smooth as possible in regard to lung health.
The lively conversation homes in on asthma control and the phenomenon often referred to as ‘peak week,’ along with the prevalence and hazards of vaping and e-cigarettes affecting the school aged population. Grab your pencils and take notes!
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Episode Highlights
0:15 Introduction
2:35 Introducing Janelle Bludorn, MS, PA-C
3:27 Common heat-related illnesses
8:43 How to screen for individual health-related risks
15:27 Respiratory consequences of heat
19:49 The interplay of medicines with heat
26:49 National Weather Service HeatRisk tool
32:58 Behavioral interventions for heat-risk patients
36:27 A FEMA system for heat emergencies?
38:10 Outro
For our July episode, we are visited by Duke University’s Janelle Bludorn, PA-C, MS, for a comprehensive overview of heat-related respiratory illnesses.
Due to climate change in all regions around the world, extreme heat has become a significant environmental and occupational health hazard with heatstroke classified as a medical emergency. Listen in to better understand the serious risks of exposure to high temperatures.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Episode Highlights
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
0:16 Intro
2:29 Updated community-acquired pneumonia guidelines
5:41 Diagnostic tools for CAP following COVID-19
9:35 Procalcitonin levels as a biomarker
12:30 The CAP treatment algorithm
18:36 Best practices for antibiotic stewardship
20:40 New CAP therapies on the horizon
22:36 ACIP recommendations for vaccination
24:30 Remaining areas of CAP uncertainty
26:30 Final thoughts
27:25 Outro
Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs’ due to antimicrobial resistance.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
Comments
Download from Google Play
Download from App Store
United States